                         SEQUENCE LISTING

<110>  AAL Scientifics, Inc.
       Anversa, Piero
       Leri, Annarosa
 
<120>  C-KIT-POSITIVE BONE MARROW CELLS AND USES THEREOF

<130>  AALS-008/01WO 326000-2035

<150>  US 62/453,428
<151>  2017-02-01

<160>  18    

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Chemically synthesized oligonucleotide Myh6-Forward

<400>  1
accaacctgt ccaagttccg                                                   20


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Chemically synthesized oligonucleotide Myh6-Reverse

<400>  2
tattggccac agcgagggtc                                                   20


<210>  3
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Chemically synthesized oligonucleotide CD31-Forward

<400>  3
agctgctcca cttctgaact c                                                 21


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Chemically synthesized oligonucleotide CD31-Reverse

<400>  4
tcaagggagg acacttccac                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Chemically synthesized oligonucleotide Col3a1-Forward

<400>  5
ggtgacagag gagaaactgg                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Chemically synthesized oligonucleotide Col3a1-Reverse

<400>  6
atgtggtcca actggtcctc                                                   20


<210>  7
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Chemically synthesized oligonucleotide B2M-Forward

<400>  7
ctcggtgacc ctggtctttc                                                   20


<210>  8
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Chemically synthesized oligonucleotide B2M-Reverse

<400>  8
ttcagtatgt tcggcttccc                                                   20


<210>  9
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Chemically synthesized oligonucleotide eGFP-X

<400>  9
ggttccctag ttagccagag agc                                               23


<210>  10
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Chemically synthesized oligonucleotide eGFP-Y

<400>  10
gagtgcttca agtagtgtgt gc                                                22


<210>  11
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Chemically synthesized oligonucleotide eGFP-M

<400>  11
agcagatctt gtcttcgttg ggagtg                                            26


<210>  12
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Chemically synthesized oligonucleotide eGFP-Z

<400>  12
ccgtctgttg tgtgactctg gtaa                                              24


<210>  13
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Chemically synthesized oligonucleotide eGFP-F

<400>  13
cattggtctt aaaggtaccg agctcg                                            26


<210>  14
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Chemically synthesized oligonucleotide eGFP-L

<400>  14
gatccctcag acccttttag tcagtg                                            26


<210>  15
<211>  5
<212>  PRT
<213>  Unknown

<220>  
<223>  enterokinase cleavage site

<400>  15

Asp Asp Asp Asp Lys 
1               5   


<210>  16
<211>  609
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Mus sp. myocyte viral integrant site


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  n is a, c, g, or t

<400>  16
gntagaattc gccccttcat tggtcttaag gtaccgagct cgaagatcat gggacagtgc       60

ccatgtctgc ttctgttgac agtggccatg acctgtttcc tggaggacaa cagcctgtag      120

ctaagttaag gtcctttaag cttgtatcca cctacattta actgggatga gacattagat      180

actgcaaatt ttgaatttaa tttccatccc aggaactcca cactttttat tctgtcacaa      240

cgtttgcgac ctgttacttg ggtaataaag aatatcttct ttaaaaaaag aaaaagacct      300

ggtagaacat ccgaaggcct gtctgcagaa ggtagatttt aaaaaaagcc tggcatacaa      360

gaatagatgt gtaactacca cgcctgtggc agcacctgct aggcaggaga ccacaggaag      420

ccagcctctt tgttctgctc aggccacttc ctagtccttg ctattcagaa taatgatgtt      480

acaggtgggc cccgctgccc ttctgcagct ccctaccacc ccagggtgat cctcagatgc      540

accctgagct gttggtggct gctagagatt ttccacactg actaaaaggg tctgagggat      600

caagggcga                                                              609


<210>  17
<211>  300
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Mus sp. endothelial viral integrant site


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  n is a, c, g, or t

<400>  17
gngttacgaa ttcgcccttc attgggtctt aaggtaccga gctcgaagtt ggcatattgg       60

tacacacctc taaagccaga atttggaagt tagaaacagg cgaatccgca tgagactgaa      120

gccagcctga tctagacagt gacttctagt ccagctagag ctagtaagaa gaccctatct      180

ttcttaaata catatacaaa caaacaaaca tacaatagta cactgctaga gattttccac      240

actgactaaa aggtctgagg gatcaagggc gaattcgcgg ccgctaaatt caattcgccc      300


<210>  18
<211>  415
<212>  DNA
<213>  Artificial Sequence

<220>  
<223>  Mus sp. myocyte viral integrant site

<400>  18
gcgcgattcg cccttcattg gtcttaaagg taccgagctc gatggttgtg agccaccacc       60

atgtggttgc tgggatttga actccagacc tttggaagag cagtcgggtg ctcttactca      120

ctgagccatc tcaccagctc aaagatttta ttataatggt ttgattgtta ccccgtcttg      180

tgctgagata tgtgataact gatcaactcc aggactttta tacaaaagga atctggactt      240

gccctcagca gtcatagatg gattaaatgt tacacatcac acgtatattt ggctgactta      300

aaacttggct ttgggaattg ctagagattt tccacactga ctaaaagggt ctgagggatc      360

aagggcgaat tcgtttaaac ctgcaggact agtcccttta gtgagggtta attct           415


